标题
Delivery of oligonucleotide‐based therapeutics: challenges and opportunities
作者
关键词
-
出版物
EMBO Molecular Medicine
Volume 13, Issue 4, Pages -
出版商
EMBO
发表日期
2021-04-06
DOI
10.15252/emmm.202013243
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Golodirsen: First Approval
- (2020) Young-A Heo DRUGS
- The 10th Oligonucleotide Therapy Approved: Golodirsen for Duchenne Muscular Dystrophy
- (2020) Annemieke Aartsma-Rus et al. Nucleic Acid Therapeutics
- Optimizing synthetic nucleic acid and protein nanocarriers: The chemical evolution approach
- (2020) Franziska Freitag et al. ADVANCED DRUG DELIVERY REVIEWS
- Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
- (2020) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characterising a healthy adult with a rare HAO1 knockout to support a therapeutic strategy for primary hyperoxaluria
- (2020) Tracy L McGregor et al. eLife
- A pharmacokinetic–pharmacodynamic model based on multi-organ-on-a-chip for drug–drug interaction studies
- (2020) Kenta Shinha et al. Biomicrofluidics
- Viltolarsen: First Approval
- (2020) Sohita Dhillon DRUGS
- Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug
- (2020) Alexandre J. Debacker et al. MOLECULAR THERAPY
- Advances in oligonucleotide drug delivery
- (2020) Thomas C. Roberts et al. NATURE REVIEWS DRUG DISCOVERY
- The chemical structure and phosphorothioate content of hydrophobically modified siRNAs impact extrahepatic distribution and efficacy
- (2020) Annabelle Biscans et al. NUCLEIC ACIDS RESEARCH
- Mist begins to clear for lung delivery of RNA
- (2020) Catherine Shaffer NATURE BIOTECHNOLOGY
- RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges
- (2020) Ai-Ming Yu et al. PHARMACOLOGICAL REVIEWS
- Inhaled RNA Therapy: From Promise to Reality
- (2020) Michael Y.T. Chow et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias
- (2019) Ronald A.M. Buijsen et al. Neurotherapeutics
- Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria
- (2019) Eliane Sardh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Shape Matters: Gold Nanoparticle Shape Impacts the Biological Activity of siRNA Delivery
- (2019) Erin Morgan et al. BIOCONJUGATE CHEMISTRY
- Reassessment of Exosome Composition
- (2019) Dennis K. Jeppesen et al. CELL
- Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index
- (2019) Wen Shen et al. NATURE BIOTECHNOLOGY
- Advances in therapeutic applications of extracellular vesicles
- (2019) Oscar P. B. Wiklander et al. Science Translational Medicine
- Inotersen: new promise for the treatment of hereditary transthyretin amyloidosis
- (2019) Veena Mathew et al. Drug Design Development and Therapy
- Evaluating the Impact of Variable Phosphorothioate Content in Tricyclo-DNA Antisense Oligonucleotides in a Duchenne Muscular Dystrophy Mouse Model
- (2019) Lucía Echevarría et al. Nucleic Acid Therapeutics
- Dendrimer-Enabled Therapeutic Antisense Delivery Systems as Innovation in Medicine
- (2019) Serge Mignani et al. BIOCONJUGATE CHEMISTRY
- Fatty acid conjugation enhances potency of antisense oligonucleotides in muscle
- (2019) Thazha P Prakash et al. NUCLEIC ACIDS RESEARCH
- Lipid Conjugates Enhance Endosomal Release of Antisense Oligonucleotides Into Cells
- (2019) Shiyu Wang et al. Nucleic Acid Therapeutics
- On the potential of in vitro organ-chip models to define temporal pharmacokinetic-pharmacodynamic relationships
- (2019) Christopher W. McAleer et al. Scientific Reports
- Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and mice
- (2019) Arnaud F. Klein et al. JOURNAL OF CLINICAL INVESTIGATION
- Multiscale reverse engineering of the human ocular surface
- (2019) Jeongyun Seo et al. NATURE MEDICINE
- The Pharmacokinetics of 2′-O-Methyl Phosphorothioate Antisense Oligonucleotides: Experiences from Developing Exon Skipping Therapies for Duchenne Muscular Dystrophy
- (2019) Sieto Bosgra et al. Nucleic Acid Therapeutics
- Merging organoid and organ-on-a-chip technology to generate complex multi-layer tissue models in a human retina-on-a-chip platform
- (2019) Kevin Achberger et al. eLife
- Glucagon-like peptide 1 (GLP-1)
- (2019) T.D. Müller et al. Molecular Metabolism
- Polyphosphazenes for the delivery of biopharmaceuticals
- (2019) Wei‐Hsin Hsu et al. JOURNAL OF APPLIED POLYMER SCIENCE
- Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
- (2019) Jinkuk Kim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identifying and Avoiding tcDNA-ASO Sequence-Specific Toxicity for the Development of DMD Exon 51 Skipping Therapy
- (2019) Philippine Aupy et al. Molecular Therapy-Nucleic Acids
- Spinal Muscular Atrophy Therapies: ICER Grounds the Price to Value Conversation in Facts
- (2019) Catherine I. Starner et al. Journal of Managed Care & Specialty Pharmacy
- Mechanism of nanoparticle-induced hypersensitivity in pigs: complement or not complement?
- (2018) János Szebeni DRUG DISCOVERY TODAY
- Morpholino oligomers tested in vitro, in biofilm and in vivo against multidrug-resistant Klebsiella pneumoniae
- (2018) Bruce L Geller et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Why dystrophin quantification is key in the eteplirsen saga
- (2018) Annemieke Aartsma-Rus et al. Nature Reviews Neurology
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
- (2018) Merrill D. Benson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
- (2018) Eugenio Mercuri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure–activity relationships and cellular mechanism of action of small molecules that enhance the delivery of oligonucleotides
- (2018) Rudolph L Juliano et al. NUCLEIC ACIDS RESEARCH
- Investigation into the Mechanism(s) That Leads to Platelet Decreases in Cynomolgus Monkeys During Administration of ISIS 104838, a 2ʹ-MOE-Modified Antisense Oligonucleotide
- (2018) Padmakumar Narayanan et al. TOXICOLOGICAL SCIENCES
- Selection of GalNAc-conjugated siRNAs with limited off-target-driven rat hepatotoxicity
- (2018) Maja M. Janas et al. Nature Communications
- The Effects of 2′-O-Methoxyethyl Oligonucleotides on Renal Function in Humans
- (2018) Stanley T. Crooke et al. Nucleic Acid Therapeutics
- A Sensitive In Vitro Approach to Assess the Hybridization-Dependent Toxic Potential of High Affinity Gapmer Oligonucleotides
- (2018) Andreas Dieckmann et al. Molecular Therapy-Nucleic Acids
- Extracellular Vesicle Heterogeneity: Subpopulations, Isolation Techniques, and Diverse Functions in Cancer Progression
- (2018) Eduard Willms et al. Frontiers in Immunology
- Stimuli-Responsive Phosphorus-Based Polymers
- (2018) Ian Teasdale EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
- Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft
- (2018) Markus Fusser et al. JOURNAL OF CONTROLLED RELEASE
- Effect of an intravitreal antisense oligonucleotide on vision in Leber congenital amaurosis due to a photoreceptor cilium defect
- (2018) Artur V. Cideciyan et al. NATURE MEDICINE
- Vesiclepedia 2019: a compendium of RNA, proteins, lipids and metabolites in extracellular vesicles
- (2018) Mohashin Pathan et al. NUCLEIC ACIDS RESEARCH
- Hydrophobicity drives the systemic distribution of lipid-conjugated siRNAs via lipid transport pathways
- (2018) Maire F Osborn et al. NUCLEIC ACIDS RESEARCH
- PLGA-Based Nanoparticles in Cancer Treatment
- (2018) Sima Rezvantalab et al. Frontiers in Pharmacology
- Targeted delivery of antisense oligonucleotides to pancreatic β-cells
- (2018) C. Ämmälä et al. Science Advances
- Engineering of small interfering RNA-loaded lipidoid-poly( DL -lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach
- (2017) Kaushik Thanki et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Mesoporous Silica Nanoparticles as Carriers for Intracellular Delivery of Nucleic Acids and Subsequent Therapeutic Applications
- (2017) Wenzhang Cha et al. MOLECULES
- Cellular uptake and trafficking of antisense oligonucleotides
- (2017) Stanley T Crooke et al. NATURE BIOTECHNOLOGY
- Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative Diseases
- (2017) Kathleen M. Schoch et al. NEURON
- Oligonucleotide Therapeutics — A New Class of Cholesterol-Lowering Drugs
- (2017) Anastasia Khvorova NEW ENGLAND JOURNAL OF MEDICINE
- A Highly Durable RNAi Therapeutic Inhibitor of PCSK9
- (2017) Kevin Fitzgerald et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
- (2017) Richard S. Finkel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Managing the sequence-specificity of antisense oligonucleotides in drug discovery
- (2017) Peter H. Hagedorn et al. NUCLEIC ACIDS RESEARCH
- Antisense oligonucleotides targeting translation inhibitory elements in 5′ UTRs can selectively increase protein levels
- (2017) Xue-hai Liang et al. NUCLEIC ACIDS RESEARCH
- Exosomes: Therapy delivery tools and biomarkers of diseases
- (2017) Lucio Barile et al. PHARMACOLOGY & THERAPEUTICS
- FDA Approval of Nusinersen for Spinal Muscular Atrophy Makes 2016 the Year of Splice Modulating Oligonucleotides
- (2017) Annemieke Aartsma-Rus Nucleic Acid Therapeutics
- Assessment of the Effects of 2′-Methoxyethyl Antisense Oligonucleotides on Platelet Count in Cynomolgus Nonhuman Primates
- (2017) Scott P. Henry et al. Nucleic Acid Therapeutics
- Inhibition of EGF Uptake by Nephrotoxic Antisense Drugs In Vitro and Implications for Preclinical Safety Profiling
- (2017) Annie Moisan et al. Molecular Therapy-Nucleic Acids
- Assessing single-stranded oligonucleotide drug-induced effects in vitro reveals key risk factors for thrombocytopenia
- (2017) Sabine Sewing et al. PLoS One
- Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-Secreted Exosome Nanovesicles for the Treatment of Brain Cancer
- (2016) Tianzhi Yang et al. AAPS Journal
- Preclinical PK/PD model for combined administration of erlotinib and sunitinib in the treatment of A549 human NSCLC xenograft mice
- (2016) Jing-yun Li et al. ACTA PHARMACOLOGICA SINICA
- Peptides for nucleic acid delivery
- (2016) Taavi Lehto et al. ADVANCED DRUG DELIVERY REVIEWS
- Electroneutral composite polymersomes self-assembled by amphiphilic polyphosphazenes for effective miR-200c in vivo delivery to inhibit drug resistant lung cancer
- (2016) Yan Peng et al. BIOMATERIALS
- A pumpless multi-organ-on-a-chip (MOC) combined with a pharmacokinetic-pharmacodynamic (PK-PD) model
- (2016) Hyuna Lee et al. BIOTECHNOLOGY AND BIOENGINEERING
- Identification and Correction of Mechanisms Underlying Inherited Blindness in Human iPSC-Derived Optic Cups
- (2016) David A. Parfitt et al. Cell Stem Cell
- Intrathecal Injections in Children With Spinal Muscular Atrophy
- (2016) Manon Haché et al. JOURNAL OF CHILD NEUROLOGY
- A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells
- (2016) Carla L. Esposito et al. JOURNAL OF CONTROLLED RELEASE
- Development of antibody-siRNA conjugate targeted to cardiac and skeletal muscles
- (2016) Tsukasa Sugo et al. JOURNAL OF CONTROLLED RELEASE
- Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA
- (2016) Sam Chen et al. JOURNAL OF CONTROLLED RELEASE
- Design of Ionizable Lipids To Overcome the Limiting Step of Endosomal Escape: Application in the Intracellular Delivery of mRNA, DNA, and siRNA
- (2016) Damien Habrant et al. JOURNAL OF MEDICINAL CHEMISTRY
- Translation efficiency of mRNAs is increased by antisense oligonucleotides targeting upstream open reading frames
- (2016) Xue-hai Liang et al. NATURE BIOTECHNOLOGY
- Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2′-modifications and enhances antisense activity
- (2016) Xue-Hai Liang et al. NUCLEIC ACIDS RESEARCH
- Establishment of a Predictive In Vitro Assay for Assessment of the Hepatotoxic Potential of Oligonucleotide Drugs
- (2016) Sabine Sewing et al. PLoS One
- Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy
- (2016) Suzan M. Hammond et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Considerations for the Characterization and Interpretation of Results Related to Alternative Complement Activation in Monkeys Associated with Oligonucleotide-Based Therapeutics
- (2016) Scott P. Henry et al. Nucleic Acid Therapeutics
- Effects of Repeated Complement Activation Associated with Chronic Treatment of Cynomolgus Monkeys with 2′-O-Methoxyethyl Modified Antisense Oligonucleotide
- (2016) Lijiang Shen et al. Nucleic Acid Therapeutics
- Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study
- (2016) Nathalie M. Goemans et al. PLoS One
- siRNA Conjugates Carrying Sequentially Assembled Trivalent N-Acetylgalactosamine Linked Through Nucleosides Elicit Robust Gene Silencing In Vivo in Hepatocytes
- (2015) Shigeo Matsuda et al. ACS Chemical Biology
- Delivery of therapeutic oligonucleotides with cell penetrating peptides
- (2015) Prisca Boisguérin et al. ADVANCED DRUG DELIVERY REVIEWS
- Clinical and Preclinical Pharmacokinetics and Pharmacodynamics of Mipomersen (Kynamro®): A Second-Generation Antisense Oligonucleotide Inhibitor of Apolipoprotein B
- (2015) Richard S. Geary et al. CLINICAL PHARMACOKINETICS
- Species-Dependent Splice Recognition of a Cryptic Exon Resulting from a Recurrent Intronic CEP290 Mutation that Causes Congenital Blindness
- (2015) Alejandro Garanto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Selective delivery of therapeutic single strand antimiRs by aptamer-based conjugates
- (2015) Silvia Catuogno et al. JOURNAL OF CONTROLLED RELEASE
- Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators
- (2015) Ulrike Flierl et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts
- (2015) Sebastien A. Burel et al. NUCLEIC ACIDS RESEARCH
- Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study
- (2015) Ole B Suhr et al. Orphanet Journal of Rare Diseases
- Scientific and Regulatory Policy Committee Points-to-consider Paper*
- (2015) Jeffery A. Engelhardt et al. TOXICOLOGIC PATHOLOGY
- Functional Characterization of the spf/ash Splicing Variation in OTC Deficiency of Mice and Man
- (2015) Ana Rivera-Barahona et al. PLoS One
- Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study
- (2014) Thomas Voit et al. LANCET NEUROLOGY
- Gold Nanoparticles for Nucleic Acid Delivery
- (2014) Ya Ding et al. MOLECULAR THERAPY
- Sequence motifs associated with hepatotoxicity of locked nucleic acid—modified antisense oligonucleotides
- (2014) Andrew D. Burdick et al. NUCLEIC ACIDS RESEARCH
- Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
- (2014) Y. Dong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antisense Oligonucleotide Therapies
- (2014) Kendall S. Frazier TOXICOLOGIC PATHOLOGY
- Phosphorothioates, Essential Components of Therapeutic Oligonucleotides
- (2014) Fritz Eckstein Nucleic Acid Therapeutics
- Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4
- (2013) M. E. Jaax et al. BLOOD
- Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans
- (2013) Mark J. Graham et al. CIRCULATION RESEARCH
- Inorganic nanomaterials as delivery systems for proteins, peptides, DNA, and siRNA
- (2013) Martin Malmsten CURRENT OPINION IN COLLOID & INTERFACE SCIENCE
- Endocytosis, Intracellular Traffic and Fate of Cell Penetrating Peptide Based Conjugates and Nanoparticles
- (2013) Kez Cleal et al. CURRENT PHARMACEUTICAL DESIGN
- Gene-Silencing Antisense Oligomers Inhibit Acinetobacter Growth In Vitro and In Vivo
- (2013) B. L. Geller et al. JOURNAL OF INFECTIOUS DISEASES
- Mipomersen, an Apolipoprotein B Synthesis Inhibitor, Reduces Atherogenic Lipoproteins in Patients With Severe Hypercholesterolemia at High Cardiovascular Risk
- (2013) Gregory S. Thomas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Adsorption and Release of siRNA from Porous Silica
- (2013) Jeremy L. Steinbacher et al. LANGMUIR
- Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape
- (2013) Jerome Gilleron et al. NATURE BIOTECHNOLOGY
- Genome engineering using the CRISPR-Cas9 system
- (2013) F Ann Ran et al. Nature Protocols
- Atherosclerotic geometries exacerbate pathological thrombus formation poststenosis in a von Willebrand factor-dependent manner
- (2013) Erik Westein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hepatotoxic Potential of Therapeutic Oligonucleotides Can Be Predicted from Their Sequence and Modification Pattern
- (2013) Peter H. Hagedorn et al. Nucleic Acid Therapeutics
- A Chemical View of Oligonucleotides for Exon Skipping and Related Drug Applications
- (2013) Peter Järver et al. Nucleic Acid Therapeutics
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo
- (2012) Muthusamy Jayaraman et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Organs-on-chips: breaking the in vitro impasse
- (2012) Andries D. van der Meer et al. Integrative Biology
- Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow
- (2012) Hyun Jung Kim et al. LAB ON A CHIP
- Assessing unintended hybridization-induced biological effects of oligonucleotides
- (2012) Morten Lindow et al. NATURE BIOTECHNOLOGY
- Targeted Delivery of PLK1-siRNA by ScFv Suppresses Her2+ Breast Cancer Growth and Metastasis
- (2012) Y.-d. Yao et al. Science Translational Medicine
- Antisense Oligonucleotide (AON)-based Therapy for Leber Congenital Amaurosis Caused by a Frequent Mutation in CEP290
- (2012) Rob WJ Collin et al. Molecular Therapy-Nucleic Acids
- Arginine-rich cell-penetrating peptide dramatically enhances AMO-mediated ATM aberrant splicing correction and enables delivery to brain and cerebellum
- (2011) Liutao Du et al. HUMAN MOLECULAR GENETICS
- Biodistribution of Small Interfering RNA at the Organ and Cellular Levels after Lipid Nanoparticle-mediated Delivery
- (2011) Bin Shi et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
- (2011) Sebahattin Cirak et al. LANCET
- Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
- (2011) Lydia Alvarez-Erviti et al. NATURE BIOTECHNOLOGY
- Alginate: Properties and biomedical applications
- (2011) Kuen Yong Lee et al. PROGRESS IN POLYMER SCIENCE
- Preclinical PK and PD Studies on 2′-O-Methyl-phosphorothioate RNA Antisense Oligonucleotides in the mdx Mouse Model
- (2010) Hans Heemskerk et al. MOLECULAR THERAPY
- Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
- (2010) Akin Akinc et al. MOLECULAR THERAPY
- Reconstituting Organ-Level Lung Functions on a Chip
- (2010) D. Huh et al. SCIENCE
- Antisense oligonucleotide pharmacokinetics and metabolism
- (2009) Richard S Geary Expert Opinion on Drug Metabolism & Toxicology
- In vivocomparison of 2′-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping
- (2009) Hans A. Heemskerk et al. JOURNAL OF GENE MEDICINE
- Rational Design of Antisense Oligomers to Induce Dystrophin Exon Skipping
- (2009) Chalermchai Mitrpant et al. MOLECULAR THERAPY
- Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents
- (2009) C. A. Stein et al. NUCLEIC ACIDS RESEARCH
- Cross-species comparison of in vivo PK/PD relationships for second-generation antisense oligonucleotides targeting apolipoprotein B-100
- (2008) Rosie Z. Yu et al. BIOCHEMICAL PHARMACOLOGY
- Accessing the therapeutic potential of immunostimulatory nucleic acids
- (2008) Winfried Barchet et al. CURRENT OPINION IN IMMUNOLOGY
- Chemically modified siRNA: tools and applications
- (2008) J WATTS et al. DRUG DISCOVERY TODAY
- The influence of chitosan content in cationic chitosan/PLGA nanoparticles on the delivery efficiency of antisense 2′-O-methyl-RNA directed against telomerase in lung cancer cells
- (2008) S. Taetz et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Most mammalian mRNAs are conserved targets of microRNAs
- (2008) R. C. Friedman et al. GENOME RESEARCH
- A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
- (2008) Akin Akinc et al. NATURE BIOTECHNOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started